Q2 2010

Filed Aug 13, 2010 · 10-Q · 44 days after period end · 0001193125-10-188951

Q2 2010 · 10-Q

Revenue

$1.13M

no prior Q2 2009 on file

Net Income

-$7.62M

no prior Q2 2009 on file

EPS Diluted

-$0.07

no prior Q2 2009 on file

Operating Income-$4,975,963—

Margins · derived

Same quarter

no prior Q2 2009 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Jun 30, 2010 · filed Aug 13, 2010 · 44 d after period end

Inovio Pharmaceuticals, Inc. · CIK 1055726 · Engraved from SEC EDGAR